Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elicio Therapeutics (ELTX) Treasury Shares (2020 - 2026)

Elicio Therapeutics filings provide 3 years of Treasury Shares readings, the most recent being $150000.0 for Q4 2023.

  • On a quarterly basis, Treasury Shares changed N/A to $150000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $150000.0, a N/A change, with the full-year FY2023 number at $150000.0, changed N/A from a year prior.
  • Treasury Shares hit $150000.0 in Q4 2023 for Elicio Therapeutics, roughly flat from $150000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $480943.0 in Q2 2021 to a low of $14455.0 in Q2 2023.
  • Median Treasury Shares over the past 3 years was $316088.0 (2020), compared with a mean of $244926.7.